Perfil epidemiológico de pacientes com diagnóstico de câncer de mama no Pará entre os anos 2020 a 2024

Abstract

Introduction: Introduction: Epidemiological studies play a crucial role in understanding cancer, a malignant disease that has been a significant cause throughout history. Cancer is characterized by the formation of neoplastic cells and the rapid dissemination capacity within the body. Such studies provide valuable information on the incidence, risk factors, clinical characteristics, and outcomes of breast cancer, enabling the development of effective strategies for prevention, diagnosis, and treatment. Objective: The objective of this study was to characterize the clinical and epidemiological profile of patients diagnosed with breast cancer between 2020 and 2024. Methodology: A descriptive study was carried out, based on data from DATASUS in order to identify the clinical profile-epidemiological analysis of patients diagnosed with breast cancer from 2020 to 2024. Results and discussion: During the period analyzed, breast cancer was more common in women, with 1,535 registered cases, compared to just 16 cases in men. The most prevalent age group for diagnosis was between 40 and 44 years old, with 206 cases, followed by the 45 to 49 years old group, with 189 cases. There was significant variation in incidence between cities, with Belém presenting the highest number of cases (756 records) and other cities with very low numbers, such as São Caetano de Odivelas and Santa Cruz do Arari, with only 3 cases each. Delivery of test results occurred within 0 to 10 days in most cases, although in some cases there were delays of more than 30 days. These results highlight the importance of awareness, early detection and improving the efficiency of healthcare processes related to breast cancer. Conclusion: The research provided valuable information about the clinical-epidemiological profile of breast cancer during the period analyzed. The results highlighted the higher incidence of the disease in women, the most affected age groups and significant regional variations. This information is essential to identify risk groups, target prevention and treatment strategies, and improve the efficiency of healthcare systems as breast cancer continues to be a challenge for the medical community, highlighting the need for continued research and innovative strategies to improve outcomes.